Clinical Trials Logo

Specific Phobias clinical trials

View clinical trials related to Specific Phobias.

Filter by:
  • None
  • Page 1

NCT ID: NCT03095482 Completed - Specific Phobias Clinical Trials

tDCS-Augmented Exposure Therapy for Pathological Fear

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

This double-blind randomized controlled clinical trial aims to test whether transcranial direct current stimulation (tDCS) can be used to modulate fear extinction learning during exposure therapy for pathological fear, including fear of spiders, snakes, or germs / contamination. Participation takes place over three laboratory visits, including (1) a pre-treatment visit, (2) a treatment and post-treatment visit, and (3) a 1 month follow-up visit. During treatment, participants will receive either 20 minutes of active or sham tDCS, followed by 30 minutes of in vivo exposure therapy.

NCT ID: NCT02605668 Completed - Panic Disorder Clinical Trials

Providing Tools for Effective Care and Treatment of Anxiety Disorders

PROTECT-AD
Start date: December 12, 2015
Phase: N/A
Study type: Interventional

PROTECT-AD is a cognitive behavioral treatment study involving highly qualified psychotherapeutic centers at seven German universities. It is our goal to further investigate and optimize existing effective treatments of anxiety disorders. In order to achieve this, the investigators want to investigate the effect of extinction learning in an "intensified" psychological intervention on treatment outcome in adults and children with anxiety disorders. The intensified psychological intervention is characterized by a higher number of exposure trials over a short time period. In the control condition the exposure trials take place in a weekly interval, analog to standard care.

NCT ID: NCT01849432 Completed - Clinical trials for Posttraumatic Stress Disorder

Study of Brain Circuitry in Anxiety Disorders

Start date: December 2006
Phase: N/A
Study type: Observational

A diverse body of research has implicated the amygdalo-cortical circuitry in the pathophysiology of anxiety disorders. For example, one model of PTSD posits exaggerated amygdala responsivity to threat-related stimuli as well as deficient top-down modulation of amygdala responses by specific cortical regions, including the pregenual anterior cingulate cortex, subcallosal cortex, and hippocampus. The investigators propose to investigate the pathophysiology of several specific anxiety disorders, Posttraumatic Stress Disorder (PTSD), Panic Disorder (PD), and Specific Phobia(SP), by using cognitive activation paradigms and magnetic resonance imaging (MRI) to probe the function and structure of implicated amygdalo-cortical circuitry.